Dominik Parsch
Overview
Explore the profile of Dominik Parsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Niemeyer P, Ludwig K, Werner M, Bernd L, Parsch D
World J Surg Oncol
. 2004 Nov;
2:38.
PMID: 15555083
Background: Benign fibrous histiocytomas (BFH) usually presents as a small benign lesion that predominantly occurs in the skin. Only few cases of BFH arising from bone have been reported, its...
12.
Parsch D, Diehm C, Schneider S, New A, Breusch S
Acta Orthop Scand
. 2004 Jul;
75(3):269-75.
PMID: 15260418
Background: There are few studies on the effect of acetabular cup design on cement penetration. Material And Methods: We evaluated the effects of an acetabular flange on cement pressurization and...
13.
Parsch D, Diehm C, New A, Schneider S, Breusch S
J Arthroplasty
. 2004 Apr;
19(3):381-6.
PMID: 15067656
In this cadaver study, we compared 2 different acetabular cement pressurizers (Exeter and Bernoski type) in paired human acetabula with simulated intraosseous bleeding. Pressure transducers were used to record intra-acetabular...
14.
Dixon M, Parsch D, Brown R, Scott R
J Arthroplasty
. 2004 Jan;
19(1):19-22.
PMID: 14716645
The clinical and radiologic outcome of 10 patients (12 knees) with a mean varus deformity of 24 degrees (range, 20 degrees to 40 degrees ) treated with total knee arthroplasty...
15.
Parsch D, Fellenberg J, Brummendorf T, Eschlbeck A, Richter W
J Mol Med (Berl)
. 2003 Dec;
82(1):49-55.
PMID: 14647922
Chondrocyte ex vivo expansion currently performed to replace damaged articular surfaces is associated with a loss of telomeric repeats similar to decades of aging in vivo. This might affect the...
16.
Fellenberg J, Krauthoff A, Pollandt K, Delling G, Parsch D
Lab Invest
. 2003 Nov;
84(1):113-21.
PMID: 14631380
Histologic response to chemotherapy is currently the strongest prognostic factor in high-grade osteosarcoma, but it can only be assessed after several weeks of therapy. Thus, detection of chemosensitivity at the...
17.
Parsch D, Lehner B, Loew M
J Shoulder Elbow Surg
. 2003 Jul;
12(3):226-30.
PMID: 12851573
Twelve patients (thirteen shoulders) treated with arthroplasty for nontraumatic osteonecrosis of the humeral head were prospectively evaluated. At a mean follow-up of 30.2 months (range, 14-49 months), shoulder function assessed...
18.
Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H, et al.
Arthritis Rheum
. 2003 Feb;
48(2):418-29.
PMID: 12571852
Objective: To compare the chondrogenic potential of human bone marrow-derived mesenchymal stem cells (BMSC) and adipose tissue-derived stromal cells (ATSC), because the availability of an unlimited cell source replacing human...
19.
Schmitt H, Lemke J, Brocai D, Parsch D
Clin J Sport Med
. 2003 Jan;
13(1):6-10.
PMID: 12544157
Objective: The object of this study was to find what degenerative changes are present in the ankle (talotibiofibular) joints in former elite high jumpers at least 10 years after their...
20.
Parsch D, Brummendorf T, Richter W, Fellenberg J
Arthritis Rheum
. 2002 Nov;
46(11):2911-6.
PMID: 12428231
Objective: To investigate the contribution of clinical ex vivo expansion protocols to replicative aging of human chondrocytes. Methods: Primary human chondrocytes were cultured as monolayers after isolation from 7 articular...